The Imanova Centre for Imaging Sciences undertakes imaging science research and biomarker development.

The Imanova Centre for Imaging Sciences is a world-leading research facility based at Hammersmith Hospital. The Centre undertakes imaging science research and biomarker development, whilst considering the valuable application of this in early drug development.

Formed as an innovative alliance between Imperial College London, King’s College London, University College London and the Medical Research Council in 2011, the facility hosts world-class capabilities and a collaborative environment for both academics and commercial clients. Imanova benefits from state-of-the-art technology including scanning equipment, radio-ligand development and manufacture, and imaging research methodology.

Imanova’s research includes studies based on Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET); techniques which can be used to visualize the body’s internal structures and the movement of molecules within the body, providing valuable insight for researchers. Whilst the technology can be used in a number of research areas, it is often used in neurology to understand the innermost activities of the brain. The Imperial College London division of brain sciences works closely with Imanova, which hosts a number of Imperial-led studies in neuroscience and mental health.

The Centre also conducts a number of research projects for commercial clients, and provides a means to test early stage drugs in first-in-human trials.